Tag: AI-Driven Drug

Nuclera, a biotechnology company enabling rapid access to high-quality proteins, and leadXpro, a specialist in structure-based drug discovery, have announced a strategic scientific partnership aimed at accelerating therapeutic discovery targeting complex membrane proteins. The collaboration will combine artificial intelligence, rapid protein synthesis, and structural biology to create a faster, more efficient pathway for developing new…